Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Biting Force and Peri-Implant Bone Changes
NCT04940104Completed
- Sponsor
- The British University in Egypt
- Start
- Jan 2019
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in bruxism (2 arms), sponsored by The British University in Egypt. Primary endpoint: Change in biting force at 12 months. Started Jan 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxism
Beyond the preview
Go deeper on NCT04940104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940104.